# Regenerative Endodontic Treatment in Permanent Incisors: Two Case Reports with 6 Years of Follow-Up

**Authors:** María Biedma-Perea, Marcela Arenas-González, María José Barra-Soto, Carolina Caleza-Jiménez, David Ribas-Pérez

PMC · DOI: 10.3390/children13020246 · 2026-02-10

## TL;DR

Regenerative endodontic treatment successfully healed and strengthened immature permanent teeth over six years, offering a durable alternative to traditional methods.

## Contribution

Long-term follow-up (over six years) confirms the durability of regenerative endodontic treatment in immature teeth.

## Key findings

- Regenerative endodontic treatment achieved stable calcified apical barriers in immature permanent incisors over six years.
- Both triple antibiotic paste and calcium hydroxide protocols provided durable clinical stability and sustained root maturation.
- Treated teeth showed complete symptom resolution and periapical healing with stable outcomes during extended follow-up.

## Abstract

What are the main findings?
Regenerative endodontic treatment achieved long-term periapical healing and structural reinforcement in three immature permanent incisors;Both triple antibiotic paste and calcium hydroxide protocols resulted in stable calcified apical barriers over more than six years of follow-up.

Regenerative endodontic treatment achieved long-term periapical healing and structural reinforcement in three immature permanent incisors;

Both triple antibiotic paste and calcium hydroxide protocols resulted in stable calcified apical barriers over more than six years of follow-up.

What are the implications of the main findings?
Regenerative procedures represent a reliable alternative for managing necrotic immature teeth, even in cases where apexification has previously failed;Extended follow-up confirms that regenerative approaches can provide durable clinical stability and sustained root maturation in pediatric patients.

Regenerative procedures represent a reliable alternative for managing necrotic immature teeth, even in cases where apexification has previously failed;

Extended follow-up confirms that regenerative approaches can provide durable clinical stability and sustained root maturation in pediatric patients.

Background: Regenerative endodontic treatment (RET) has emerged as a biologically based alternative to traditional apexification for managing immature permanent teeth with pulp necrosis. By promoting tissue ingrowth and continued root development, RET aims not only to eliminate infection but also to reinforce structurally compromised roots. Although its clinical use has expanded, evidence regarding the long-term predictability and durability of RET remains limited, as most published studies provide only short- or mid-term follow-up. Case presentation: This report describes two pediatric cases involving regenerative procedures performed on three immature permanent maxillary incisors, each followed for more than six years. The first case involved a 7-year-old girl who developed pulp necrosis in a maxillary lateral incisor after acute dental trauma. Management followed a regenerative protocol using triple antibiotic paste (ciprofloxacin, metronidazole, and minocycline) as intracanal medication and mineral trioxide aggregate as the coronal barrier. The second case concerned an 8-year-old girl presenting with chronic infection and sinus tracts affecting both maxillary central incisors. These teeth were treated using a regenerative approach with calcium hydroxide as the intracanal medicament and Biodentine as the sealing material. Clinical, radiographic, and cone beam computed tomography evaluations demonstrated complete symptom resolution and periapical healing but incomplete progressive apical closure. All treated teeth developed a calcified apical barrier, and outcomes remained stable throughout the extended follow-up period. Conclusions: While inherently limited by the nature of case reports, these findings support RET as a reliable and durable therapeutic option for necrotic immature permanent teeth, including cases in which conventional apexification has not been successful.

## Linked entities

- **Chemicals:** ciprofloxacin (PubChem CID 2764), metronidazole (PubChem CID 4173), minocycline (PubChem CID 54675783)
- **Diseases:** pulp necrosis (MONDO:0001326)

## Full-text entities

- **Genes:** RET (ret proto-oncogene) [NCBI Gene 5979] {aka CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1}
- **Diseases:** cytotoxicity (MESH:D064420), infected (MESH:D007239), tooth discoloration (MESH:D014075), blood (MESH:D006402), necrotic (MESH:D009336), fistulas (MESH:D005402), endodontic infections (MESH:D011671), tenderness (MESH:D063806), pulp fracture (MESH:D003788), resorption (MESH:D014091), root fractures (MESH:D011843), calcification (MESH:D002114), pain (MESH:D010146), pulp necrosis (MESH:D003790), dental trauma (MESH:D014947), abscess (MESH:D000038), inflammatory (MESH:D007249), REPs (MESH:D000073818), apical periodontitis (MESH:D010485), dentin fracture (MESH:D003805), Bleeding (MESH:D006470)
- **Chemicals:** NaOCl (MESH:D012973), Ca(OH)2 (MESH:D002126), fosfomycin (MESH:D005578), Er, Cr:YSGG (-), Septodont (MESH:C034472), curcumin (MESH:D003474), calcium (MESH:D002118), acetate (MESH:D000085), minocycline (MESH:D008911), polyphenol (MESH:D059808), Biodentine (MESH:C506393), ciprofloxacin (MESH:D002939), metronidazole (MESH:D008795), alpha-mangostin (MESH:C021053), graphene oxide (MESH:C000628730), EDTA (MESH:D004492), polyethylene glycol (MESH:D011092), amoxicillin and clavulanate (MESH:D019980), Octenisept (MESH:C000718682), EGCG (MESH:C045651), MTA (MESH:C086631), PEG-400 (MESH:C000595213), alexidine (MESH:C001570)
- **Species:** Homo sapiens (human, species) [taxon 9606], Candida albicans (species) [taxon 5476], Enterococcus faecalis (species) [taxon 1351]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939366/full.md

---
Source: https://tomesphere.com/paper/PMC12939366